Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTM2 | P28161 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 6/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | MYC | P01106 | 7/20 | 0.57 |
| ▸ | MAX | P61244 | 3/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.57 |
| ▸ | IDO1 | P14902 | 3/20 | 0.56 |
| ▸ | MIF | P14174 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14617994 | 0.92 | GSTM2 (0.72) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL592618 | 0.90 | GSTM2 (0.76) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL15516469 | 0.90 | GSTM2 (0.76) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL15515612 | 0.90 | GSTM2 (0.76) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL31320442 | 0.90 | GSTM2 (0.76) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL459120 | 0.90 | GSTM2 (0.76) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL285019 | 0.90 | GSTM2 (0.76) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL10824789 | 0.86 | MEN1 (0.66) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL18056383 | 0.86 | GSTM2 (0.63) | GSTM2MEN1KMT2AUSP2HTT | |
| SCHEMBL31580439 | 0.85 | GSTM2 (0.59) | GSTM2MEN1KMT2AUSP2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9773953-B2 | Organic phosphor-functionalized nanoparticles and compositions comprising the same | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2017-09-26 | — | — | US | disclosed |
| US-20160049559-A1 | ORGANIC PHOSPHOR-FUNCTIONALIZED NANOPARTICLES AND COMPOSITIONS COMPRISING THE SAME | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2016-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160049559-A1 | ORGANIC PHOSPHOR-FUNCTIONALIZED NANOPARTICLES AND COMPOSITIONS COMPRISING THE SAME | CLTA, CLTB, CLTC | GSTM2 1131/4885MEN1 4323/4885KMT2A 3306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.